Cross Country Healthcare (NASDAQ:CCRN) rose 3.3% after a report that the company's planned sale to Aya Healthcare likely won't be the subject of a Federal Trade Commission meeting next week.
Third-party depositions are still happening in the FTC's review of the deal, according to a CTFN report on Thursday, which cited a third party who has been deposed.
Cross Country Healthcare (NASDAQ:CCRN) shares sunk 5% on Wednesday on investor speculation that the company's planned $615 million sale to Aya may be the subject of the FTC closed-doore meeting. The FTC's review of the deal has discovered some "troubling documents," according to a CTFN report in March, which cited a source familiar with the matter.
The closed-door meeting may be related to a consumer protection item, according to the CTFN report on Thursday.
In March, Cross Country (NASDAQ:CCRN) received a second request from the FTC about the travel nursing company's planned sale to Aya.
Aya Healthcare in December entered into a definitive agreement to acquire Cross Country for $18.61/share in cash.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.